Results for:(81 found)
Jul 30, 2012 8:53AM on Top StocksBy Jonathan Berr

JP Morgan, PetSmart and Eli Lilly are downgraded.

Jul 25, 2012 12:44PM on Top StocksBy MSN Money Partner

Stocks are mixed as Apple earnings weigh on the Nasdaq but improved outlooks from Boeing and Caterpillar support the Dow.

Jul 23, 2012 10:38AM on Top StocksBy Jim Cramer

When mindless losers dump stocks in Europe-inspired sell-offs, you can pick up bargains.

Jul 2, 2012 2:35PM on Top StocksBy Minyanville

The transaction also includes a $3.4 billion payment from AstraZeneca as the big drug companies try to replace lost sales from products with generic competition.

Jul 2, 2012 8:38AM on Top StocksBy MSN Money Partner

The diabetes drugmaker is being acquired, and the chairman of the financial firm is resigning.

Jun 28, 2012 1:44PM on Top StocksBy Kim Peterson

Hospital stocks and Medicaid insurers saw big gains after the Supreme Court's ruling, while other health care stocks dropped.

Jun 27, 2012 3:04AM on Top StocksBy Gene Marcial

Pharmaceuticals led by Lilly, Roche and Pfizer have exciting drugs to fire up their growth.

Apr 16, 2012 12:21PM on TechBizBy MSN Money Partner

New names may be popular, but old tech is still the place to put long-term money.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More